FdaApplication
NDA 215842
Identifiers
- fda_app_no: NDA215842
Properties
| Property | Value |
|---|---|
| applicant_name | NOVO NORDISK INC |
| application_type | NDA |
| approval_date | 2023-09-29 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| RIVFLOZA | NEDOSIRAN SODIUM | EQ 128MG BASE/0.8ML (EQ 160MG BASE/ML) | SOLUTION;INJECTION |
| RIVFLOZA | NEDOSIRAN SODIUM | EQ 160MG BASE/ML (EQ 160MG BASE/ML) | SOLUTION;INJECTION |
| RIVFLOZA | NEDOSIRAN SODIUM | EQ 80MG BASE/0.5ML (EQ 160MG BASE/ML) | SOLUTION;INJECTION |
3 products